Dr Jay Caesar Moreland, MD | |
220 W 7200 S Ste A, 72nd Street Clinic, Chc Inc, Midvale, UT 84047-1043 | |
(801) 566-5494 | |
(801) 561-9647 |
Full Name | Dr Jay Caesar Moreland |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 32 Years |
Location | 220 W 7200 S Ste A, Midvale, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023095866 | NPI | - | NPPES |
G06469 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 263407-1205 (Utah) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Health Centers Inc | 5991698169 | 31 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
"Tanzania is to become the first country in the world to move exclusively to using syringes that self-destruct after a British entrepreneur played the health minister undercover footage of children being injected with used needles," the Guardian reports.
A simpler form of testing individuals with risk factors for diabetes could improve diabetes prevention efforts by substantially increasing the number of individuals who complete testing and learn whether or not they are likely to develop diabetes.
BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.
› Verified 2 days ago
Entity Name | Community Health Centers Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952505117 PECOS PAC ID: 5991698169 Enrollment ID: O20040203000767 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
"Tanzania is to become the first country in the world to move exclusively to using syringes that self-destruct after a British entrepreneur played the health minister undercover footage of children being injected with used needles," the Guardian reports.
A simpler form of testing individuals with risk factors for diabetes could improve diabetes prevention efforts by substantially increasing the number of individuals who complete testing and learn whether or not they are likely to develop diabetes.
BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jay Caesar Moreland, MD 220 W 7200 S Ste A, 72nd Street Clinic, Chc Inc, Midvale, UT 84047-1043 Ph: (801) 566-5494 | Dr Jay Caesar Moreland, MD 220 W 7200 S Ste A, 72nd Street Clinic, Chc Inc, Midvale, UT 84047-1043 Ph: (801) 566-5494 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
"Tanzania is to become the first country in the world to move exclusively to using syringes that self-destruct after a British entrepreneur played the health minister undercover footage of children being injected with used needles," the Guardian reports.
A simpler form of testing individuals with risk factors for diabetes could improve diabetes prevention efforts by substantially increasing the number of individuals who complete testing and learn whether or not they are likely to develop diabetes.
BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that it completed a registered public offering of 19,818,972 shares of common stock at a price per share of $0.29 and warrants to purchase 14,864,229 shares of common stock at an exercise price of $0.29 per share, representing gross proceeds of $5,747,502.
› Verified 2 days ago
Dr. Katie Lynn Donnelly, APRN, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 65 E 6850 S, Midvale, UT 84047 Phone: 307-259-8362 | |
Grace Kim Harris, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1225 E Fort Union Blvd, Suite 200, Midvale, UT 84047 Phone: 801-233-4400 Fax: 801-233-4410 | |
Larisa B. Yaroshchuk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7495 S State St, Midvale, UT 84047 Phone: 801-213-9400 | |
Hugo Rivas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7259 S Bingham Junction Blvd, Midvale, UT 84047 Phone: 915-213-4218 | |
Timothy P Young, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 779 W Coliseum Way Ste A, Midvale, UT 84047 Phone: 385-240-0060 Fax: 385-240-0031 | |
Layne Lloyd, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Fort Union Blvd, Suite 200, Midvale, UT 84047 Phone: 801-233-4400 Fax: 801-233-4410 |